Marcus Thorne, US Social Affairs Reporter

Marcus Thorne focuses on the critical social issues shaping modern America, from civil rights and immigration to healthcare disparities and urban development. With a background in sociology and 15 years of investigative reporting for ProPublica, Marcus is dedicated to telling the stories of underrepresented communities. His long-form features have sparked national conversations on social justice reform.
2356 Articles

Political Turmoil: House Vote on Swalwell’s Expulsion Looms Amid Allegations

The U.S. House of Representatives is poised to deliberate the potential expulsion…

Trio Arrested in Bold $1 Million Lego Theft in California

** In a remarkable turn of events, three men have been apprehended…

New Hope for Ovarian Cancer Patients: Repurposed Drug Shows Promise in Clinical Trials

A groundbreaking clinical trial has revealed that relacorilant, a medication originally designed…

Pope Leo Condemns ‘Delusion of Omnipotence’ Amid U.S.-Israeli Conflict in Iran

** In a striking escalation of his rhetoric, Pope Leo has denounced…

Three California Men Arrested in Ambitious $1 Million Lego Theft

Three men have found themselves behind bars following an audacious heist involving…

Democratic Contenders Gather at National Action Network Convention, Setting the Stage for 2028

The National Action Network's recent convention served as a significant platform for…

Pope Leo Criticises ‘Delusion of Omnipotence’ Amid Conflict in the Middle East

Pope Leo has raised significant concerns regarding the ongoing conflict between the…

Insights from the National Action Network Convention: A Glimpse into the 2028 Democratic Landscape

The recent National Action Network (NAN) convention served as a significant platform…

Promising New Treatment Offers Hope for Patients with Platinum-Resistant Ovarian Cancer

Recent findings from clinical trials highlight a potential breakthrough in the treatment…

New Hope for Ovarian Cancer Patients as Repurposed Drug Shows Promise in Clinical Trials

A recently published clinical trial suggests that relacorilant, a medication initially developed…

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy